Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

NOVAG ANTIGRIPAL GRANULADO PARA SOLUCION ORAL - CIMA-AEMPS Drug Approval Details

Approvals/CIMA-AEMPS/NOVAG ANTIGRIPAL GRANULADO PARA SOLUCION ORAL

Approved

STANDARD

NOVAG ANTIGRIPAL GRANULADO PARA SOLUCION ORAL

Tarbis Farma S.L.🇪🇸 Spanish Agency of Medicines and Medical Devices

Approval Date: Jun 30, 2020
Approval ID: 8a98ae54aaecff74
Company: Tarbis Farma S.L.
Type: Standard

Approval Details

Approval Id: 8a98ae54aaecff74
Drug Cima Aemps Name: NOVAG ANTIGRIPAL GRANULADO PARA SOLUCION ORAL
Register Number: 85217
Holder Company Name: Tarbis Farma S.L.
Marketing Company Name: Tarbis Farma S.L.
Authorization Date: 2020-06-30
Dosage Form: GRANULADO PARA SOLUCIÓN ORAL
Dose: 650 / 15.58 / 4 mg
Route Of Administration: VÍA ORAL
Prescription Type: Sin Receta
Commercialized: Yes
Company Name: Tarbis Farma S.L.

Active Ingredients

PARACETAMOL

650 mg

FENILEFRINA BITARTRATO

15,58 mg

CLORFENAMINA MALEATO

4 mg

Approved

Quick Info

Agency

CIMA-AEMPS

Country

🇪🇸

Approval Date

Jun 30, 2020

Approval ID

8a98ae54aaecff74

Type

Standard

Back to CIMA-AEMPS Approvals